SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare informs about company updates

22 Aug 2018 Evaluate

Themis Medicare has informed that the Company’s Haridwar Plant has been granted a Certificate by European Union - Good Manufacturing Practice (EU-GMP) for Company’s oral and topical manufacturing sections. With this, the Company can commercialise its products in the European Union (EU) countries. This certification will also give access to the Company to commercialise its products in the Pharmaceutical Inspection Co-operation Scheme (PICS) markets for Company’s products manufactured at Company’s State of-the-Art manufacturing facility at Haridwar.

The above information is a part of company’s filings submitted to BSE.

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×